Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Cesca Therapeutics Inc

+ Add to Watchlist


0.730 EUR 0.001 0.14%

As of 09:35:06 ET on 05/28/2015.

Snapshot for Cesca Therapeutics Inc (THRA)

Open: 0.728 Day's Range: 0.706 - 0.756 Volume: 0
Previous Close: 0.729 52wk Range: 0.632 - 1.400 1-Yr Rtn: -42.11%

Stock Chart for THRA

No chart data available.
  • THRA:GR 0.756
  • 1D
  • 1M
  • 1Y
Interactive THRA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THRA

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) -0.3900
Est. PEG Ratio -
Market Cap (M EUR) 29.50
Shares Outstanding (M) 40.42
30 Day Average Volume 538
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THRA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THRA

Cesca Therapeutics, Inc. operates as a supplier of products targeting the worldwide adult stem cell market. The Company offers automated and semi-automated devices and single-use processing disposables that enable the collection, processing and cryopreservation of stem cells and other cellular tissues from cord blood and bone marrow used in regenerative medicine.

Robin C StraceyInterim CEOKenneth L Harris "Ken"President
Michael BruchInterim CFO/ControllerMitchel Sivilotti "Mitch"Chief Biologist
More Company Profile & Key Executives for THRA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil